Ghana’s healthtech startup mPharma has appointed Kwesi Arhin as its new CEO, effective September 1, 2025, marking a pivotal shift in leadership.
Gregory Rockson’s incredible 12-year tenure as mPharma’s co-founder and CEO, during which he turned the business into a significant force in Africa’s pharmaceutical supply chain, ends with this change.
As chairman, Rockson will now oversee strategy and investor relations while Arhin oversees day-to-day operations.
Kwesi Arhin, formerly Chief Operating Officer, is the first non-founder to take up the CEO role at mPharma. His experience managing finance, supply chain, and operational strategy is expected to sharpen the company’s focus on efficiency and scalability.
Arhin is a Fellow of the Association of Chartered Certified Accountants (FCCA), bringing substantial financial and operational expertise to the role. Industry watchers anticipate that his leadership will enhance mPharma’s inventory and logistics systems, boosting margins and operational discipline.
Legacy of Gregory Rockson and expansion plans
Since launching mPharma in 2012, Gregory Rockson has built the startup into a healthtech innovator linking over 7,000 pharmacies across Ghana, Nigeria, and Kenya to medicine manufacturers.
Rockson’s daring expansion introduced new services and software like Bloom, revolutionising drug access and affordability in African markets.
He said, “mPharma has come a long way, but the work is far from over. The next chapter will be even more impactful as we scale operations and improve healthcare access in Africa.”
With almost $95 million raised through several funding rounds, mPharma’s rapid growth reflects investor confidence in its mission to tackle drug shortages and inefficiencies.
The leadership handover to Arhin signals a strategic shift from founder-led vision to execution-driven management. Stakeholders will now watch how the new CEO balances operational rigour with the bold ambition that defined Rockson’s tenure.
This change is necessary to advance mPharma’s footprint across Africa and accelerate access to essential medicines.